Advertisement

Topics

Helios BioSciences Company Profile

17:26 EDT 18th June 2018 | BioPortfolio

The quick selection at low cost of relevant therapeutic targets is one of today major challenges facing the Biotech companies and pharmaceutical industry. The evaluation of the genes involved in a given pathology is a privileged axis for the identification of new therapeutic targets.Helios Biosciences proposes a new paradigm to effectively characterize therapeutic targets, : the dynamic modeling of molecular cascades of signal transductions.

Location

8, avenue du Général Sarrail
Créteil
Cedex
94010
France

Contact

Phone: 33 1 49 81 37 92
Email: info@heliosbiosciences.com


News Articles [643 Associated News Articles listed on BioPortfolio]

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

AESKU nDNA (Crithidia luciliae) now FDA cleared with HELIOS System

AESKU Receives FDA 510(k) Clearance for nDNA (Crithidia luciliae) with the HELIOS AUTOMATED IFA SYSTEM Wendelsheim, Germany / Oakland, California (PRWEB) March 13, 2018 AESKU.GROUP – a science-focu...

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

Kuros Biosciences Ltd.: Kuros Biosciences weitet Lizenzabkommen mit Checkmate aus

Schlieren (Zürich), Schweiz, 8. Januar 2018 Kuros Biosciences weitet Lizenzabkommen mit Checkmate aus Kuros Biosciences AG (SIX: KURN) gibt die Ausdehnung des exklusiven Lizenzabkommens mit Checkm...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women...

Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that ...

Apricus Biosciences, Inc.: Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros

Company Evaluating Deficiencies and Potential Path Forward SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative me...

Kaskela Law LLC: IMPORTANT SHAREHOLDER DEADLINE ALERT: Solid Biosciences, Inc. - SLDB

RADNOR, PA / ACCESSWIRE / May 23, 2018 / Kaskela Law LLC reminds Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") investors that a class action complaint has been filed...

PubMed Articles [74 Associated PubMed Articles listed on BioPortfolio]

Downregulation in Helios transcription factor signaling is associated with immune dysfunction in blood leukocytes of autistic children.

Autism spectrum disorder (ASD) is a complex heterogeneous neurodevelopmental disorder in which immunological imbalance has been suggested to be a major etiological component. Helios, a transcription f...

Association of Regulatory T Cells with Diabetes Type-1 and Its Renal and Vascular Complications Based on the Expression of Forkhead Box Protein P3 (FoxP3), Helios and Neurophilin-1.

In recent years, it has been recognized that regulatory T cells (Tregs) play a critical role in maintaining immune tolerance. Moreover, the expression of two markers named Helios and neurophilin-1 (NR...

Expression of TIGIT and FCRL3 is Altered in T Cells from Patients with Distinct Patterns of Chronic Autoimmune Thyroiditis.

Co-inhibitory receptors (IR), such as TIGIT and FCRL3, provide a checkpoint against highly destructive immune responses. Co-expression of TIGIT and FCRL3, in particular, has been linked to the HELIOS ...

Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed Rheumatoid Arthritis patients.

The control of auto-reactive cells is defective in rheumatoid arthritis (RA). Regulatory T (Treg) cells which play a key role in the modulation of immune responses have an impaired function in RA. Fox...

Introduction.

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Low-dose Digital Radiographs in the Idiopathic Scoliosis

The aim of the study is to evaluate the intraobserver repeatability and the interobserver reproducibility of low-dose radiographs with a HELIOS DRF (CAT) imaging system in patients with id...

SEP Changes During Deep Anesthesia

The relation between burst and suppression periods in transcranial and direct cortical recorded EEG with cortical amplitudes median nerve somatosensory evoked potentials is studied. ...

The HELIOS-Study: Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium (BY217/M2-128)

The aim of the study is to compare the efficacy of roflumilast to placebo on pulmonary function and symptomatic parameters in patients with chronic obstructive pulmonary disease (COPD) dur...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Companies [351 Associated Companies listed on BioPortfolio]

Helios BioSciences

The quick selection at low cost of relevant therapeutic targets is one of today major challenges facing the Biotech companies and pharmaceutical industry. The evaluation of the genes involved in a giv...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

More Information about "Helios BioSciences" on BioPortfolio

We have published hundreds of Helios BioSciences news stories on BioPortfolio along with dozens of Helios BioSciences Clinical Trials and PubMed Articles about Helios BioSciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Helios BioSciences Companies in our database. You can also find out about relevant Helios BioSciences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record